Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Patients with Open-Angle Glaucoma: A Systematic Review and Meta-analysis
- PMID: 40758055
- DOI: 10.1097/IJG.0000000000002616
Standalone Canaloplasty and Trabeculotomy Using the OMNI Surgical System in Patients with Open-Angle Glaucoma: A Systematic Review and Meta-analysis
Abstract
Precis: This systematic review and meta-analysis found that standalone OMNI resulted in significant intraocular pressure (IOP) reduction at the 1-month, 6-month, 1-year, and 2-year time points and significantly improved topical medication burden at 1-year.
Purpose: To determine the efficacy of standalone canaloplasty and trabeculotomy using the OMNI Surgical System in open-angle glaucoma (OAG) patients.
Methods: A systematic review was performed using the PubMed, Embase, and Scopus databases for all studies using the OMNITM Surgical System for standalone canaloplasty and trabeculotomy in OAG patients with baseline intraocular pressure (IOP) >18 mmHg (PROSPERO ID: CRD420251044505). Meta-analyses were performed to calculate the IOP change following treatment at 1-month, 6-month, 1-year, and 2-year follow-ups. We also evaluated changes in topical medications and the proportion of medication-free patients at 1 year.
Results: Five studies with 290 eyes at baseline were included. At the 1-month follow-up, there was a significant mean IOP reduction of 7.40 mmHg following standalone OMNI (MD=-7.40; 95% CI: -10.61 to -4.20; P<0.0001). At the 6-month follow-up, mean IOP reduction was 7.25 mmHg (MD=-7.25; 95% CI: -9.60 to -4.89; P<0.0001). At the 1-year follow-up, mean IOP reduction was 7.49 mmHg (MD=-7.49; 95% CI: -9.47 to -5.50; P<0.0001). At 2-year follow-up, mean IOP reduction was 8.77 mmHg (MD=-8.77; 95% CI: -10.35 to -7.19; P<0.0001). Additionally, at the 1-year follow-up, mean reduction of topical medications was 0.77 (MD=-0.77; 95% CI: -1.44 to -0.09; P=0.025), and 46.2% of patients were medication-free (95% CI: 35.6%-57.2%).
Conclusions: The OMNI Surgical System is an effective standalone procedure for canaloplasty and trabeculotomy in OAG patients and led to a significant reduction in IOP at multiple timepoints and medication burden.
Keywords: MIGS; OMNI; canaloplasty; glaucoma; minimally invasive glaucoma surgeries; trabeculotomy.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.Cochrane Database Syst Rev. 2017 Feb 23;2(2):CD010746. doi: 10.1002/14651858.CD010746.pub2. Cochrane Database Syst Rev. 2017. PMID: 28231380 Free PMC article.
-
Retrospective Study of 2-year Clinical Outcomes of Combination Ab-Interno Canaloplasty and a Microstent Compared to Ab-Interno Canaloplasty in Cataract Surgery Patients.Clin Ophthalmol. 2025 Jun 25;19:1991-1997. doi: 10.2147/OPTH.S519826. eCollection 2025. Clin Ophthalmol. 2025. PMID: 40584253 Free PMC article.
-
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.Cochrane Database Syst Rev. 2022 Jun 10;6(6):CD013817. doi: 10.1002/14651858.CD013817.pub2. Cochrane Database Syst Rev. 2022. PMID: 35686679 Free PMC article.
-
Efficacy and complications of microcatheter-assisted minimally invasive glaucoma surgery for open-angle glaucoma: A systematic review and network meta-analysis.Surv Ophthalmol. 2025 Jun 6:S0039-6257(25)00097-9. doi: 10.1016/j.survophthal.2025.06.001. Online ahead of print. Surv Ophthalmol. 2025. PMID: 40484184 Review.
-
Fornix-based versus limbal-based conjunctival trabeculectomy flaps for glaucoma.Cochrane Database Syst Rev. 2015 Nov 25;11(11):CD009380. doi: 10.1002/14651858.CD009380.pub2. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2021 Aug 26;8:CD009380. doi: 10.1002/14651858.CD009380.pub3. PMID: 26599668 Free PMC article. Updated.
LinkOut - more resources
Full Text Sources